Geron Corporation
GERN
Jodie situation report
Geron Corporation's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 12 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.
- GERN's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if GERN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind GERN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
INCYIncyte CorporationpartnerMar 2, 2026 ▾
“nt Inc.; elritercept ( KER-050) in combination with ruxolitinib, by Keros Therapeutics; CK0804, an allogeneic T-regulatory cell agent, by Cellenkos, Inc.”
KROSFiling-linked namepartnerMar 2, 2026 ▾
“Other therapies currently in Phase 3 development in lower-risk MDS include elritercept (KER-050), a TGF-beta inhibitor, by Keros Therapeutics, Inc.; and Reblozyl (luspatercept) in non-transfusion-dependent lower-risk MDS patients, by BMS.”
BMYBristol-Myers Squibb CompanycompetitorMar 2, 2026 ▾
“In lower-risk MDS, RYTELO competes against a number of currently existing therapies, including ESAs (Epoetin alfa, Procrit; Darbepoetin alfa, Aranesp-Amgen) that are indicated for anemia; immunomodulators, such as Revlimid (lenalidomide) by Celgene Corporatio…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
GERN is currently a Early Follower in the organic co-movement group Industrial Equipment & Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for GERN; it is not active in the latest market snapshot.